Experimental drug ampligen targets debilitating fatigue
NCT ID NCT00215813
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 31 times
Summary
This study tests an experimental drug called Ampligen in people with severe chronic fatigue syndrome (CFS). Participants must have had CFS for at least a year and be between 18 and 70 years old. The goal is to see if Ampligen can help control the disease and reduce symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC FATIGUE SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hunter-Hopkins Center, PA
Charlotte, North Carolina, 28210, United States
-
Sierra Internal Medicine
Incline Village, Nevada, 89451, United States
Conditions
Explore the condition pages connected to this study.